IL17A and COVID-19: The results showed that IL-1β, IL-2, IFN-β, IFN-γ, IL-17, GM-CSF, and TFN-α had a slightly higher correlation with metabolic phenotype 2 in non-survivors, indicating a potential association with COVID-19 mortality outcome.